NCT06918561View on ClinicalTrials.gov

Evaluating the Efficacy of NeoThelium FT in the Treatment of Chronic Open Wounds

NANot yet recruitingINTERVENTIONAL

Enrollment

132

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

October 1, 2026

Conditions

Open Wound

Interventions

OTHER

Standard of Care

Wound cleansing, Sharps debridement, Dressing for moisture balance, Offloading

OTHER

NeoThelium FT

NeoThelium FT is a dehydrated wound covering derived from donated human placental tissue. NeoThelium FT is a dual-layer membrane with amnion and chorion combination layers.

All Listed Sponsors

collaborator

SygNola, LLC

INDUSTRY

lead

NuScience Medical Biologics, LLC

INDUSTRY

NCT06918561 - Evaluating the Efficacy of NeoThelium FT in the Treatment of Chronic Open Wounds | Biotech Hunter | Biotech Hunter